From: Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers
Tumor status | N (Cases) | Prolactin levels (ng/mL) | p-heterogeneity | |
---|---|---|---|---|
 ≤ 11 |  > 11 | |||
All breast cancer | 577 | 1(Ref) | 1.37 (1.12, 1.67) | Â |
Prolactin receptor | ||||
 Nucleara | ||||
  Negative | 406 | 1 (Ref) | 1.32 (1.05, 1.66) | 0.65 |
  Positive | 139 | 1 (Ref) | 1.45 (1.01, 2.07) | |
 Cytoplasmica | ||||
  Negative | 416 | 1 (Ref) | 1.32 (1.05, 1.65) | 0.60 |
  Positive | 129 | 1 (Ref) | 1.47 (1.01, 2.14) | |
pSTAT5 | ||||
 Nucleara | ||||
  Negative | 394 | 1 (Ref) | 1.29 (1.03, 1.63) | 0.21 |
  Positive | 125 | 1 (Ref) | 1.69 (1.16, 2.46) | |
 Cytoplasmicb | ||||
  Negative | 213 | 1 (Ref) | 1.43 (1.07, 1.92) | 0.73 |
  Positive | 306 | 1 (Ref) | 1.34 (1.04, 1.73) | |
 Combined nuclear/cytoplasmic | ||||
  Both negative | 189 | 1 (Ref) | 1.45 (1.06, 1.97) | 0.53 |
  Both positive | 101 | 1 (Ref) | 1.78 (1.18, 2.68) | |
  One negative/one positive | 229 | 1 (Ref) | 1.35 (1.02, 1.80) | |
pJAK2b | ||||
 Negative | 95 | 1 (Ref) | 1.52 (0.99, 2.33) | 0.68 |
 Positive | 409 | 1 (Ref) | 1.38 (1.10, 1.73) |